Fundraising Fox
Broadwing
South San Francisco, US · 3 employees on LinkedIn · 1 known investors
Find your way into Broadwing
Sign up to see every warm intro you have to Broadwing
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Broadwing team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Broadwing Bio develops antibody-based therapies targeting genetically validated ophthalmology conditions, particularly geographic atrophy and glaucoma, to preserve vision and prevent blindness. The company builds on naturally occurring genetic variants to create novel treatments for ocular diseases.
Founders & leadership
AP
Andrew Peterson, Ph.D.Founder, CEO and board member
JC
Jennifer Cygan, Ph.D.Founder
MR
Manuel Rivas, D.PhilFounder and scientific advisory board member
Investors · 1
82VSlisted by 82VSBoston
How we know: 82VS's portfolio page · Not right? Tell us
Frequently asked questions
- What does Broadwing do?
- Broadwing Bio develops antibody-based therapies targeting genetically validated ophthalmology conditions, particularly geographic atrophy and glaucoma, to preserve vision and prevent blindness. The company builds on naturally occurring genetic variants to create novel treatments for ocular diseases.
- Who founded Broadwing?
- Broadwing was founded by Andrew Peterson, Ph.D., Jennifer Cygan, Ph.D., Manuel Rivas, D.Phil.
- Who are Broadwing's investors?
- Broadwing's investors include 82VS.
- Where is Broadwing headquartered?
- Broadwing is headquartered in South San Francisco, US.